skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: New Records: New From Last Month remove subject: Ejection Fraction remove subject: Heart remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Recovery of left ventricular systolic function in peripartum cardiomyopathy: an observational study from rural Tanzania
Material Type:
Article
Add to My Research

Recovery of left ventricular systolic function in peripartum cardiomyopathy: an observational study from rural Tanzania

BMC cardiovascular disorders, 2024-05, Vol.24 (1), p.243-243 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1471-2261 ;EISSN: 1471-2261 ;DOI: 10.1186/s12872-024-03906-y ;PMID: 38724901

Full text available

2
In vivo mitral valve repair for the transplanted donor heart in orthotopic heart transplantation
Material Type:
Article
Add to My Research

In vivo mitral valve repair for the transplanted donor heart in orthotopic heart transplantation

Journal of cardiothoracic surgery, 2024-05, Vol.19 (1), p.287-287 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1749-8090 ;EISSN: 1749-8090 ;DOI: 10.1186/s13019-024-02788-7 ;PMID: 38741144

Full text available

3
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy

European Heart Journal, 2023-11, Vol.44 (44)

public

Digital Resources/Online E-Resources

4
Health Care Roundup: Market Talk
Material Type:
Newsletter Article
Add to My Research

Health Care Roundup: Market Talk

Dow Jones Institutional News, 2024

Copyright Dow Jones & Company Inc. May 14, 2024

Digital Resources/Online E-Resources

5
Health Care Roundup: Market Talk
Material Type:
Newsletter Article
Add to My Research

Health Care Roundup: Market Talk

Dow Jones Institutional News, 2024

Copyright Dow Jones & Company Inc. May 14, 2024

Digital Resources/Online E-Resources

6
Tenaya Therapeutics (TNYA: $4.39) inches higher, resistance at 12-day EMA; +11c [2.6%]
Material Type:
Newsletter Article
Add to My Research

Tenaya Therapeutics (TNYA: $4.39) inches higher, resistance at 12-day EMA; +11c [2.6%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 15, 2024

Digital Resources/Online E-Resources

7
Tenaya Therapeutics (TNYA: $4.28) lifts 1.9%; +8c [1.9%]
Material Type:
Newsletter Article
Add to My Research

Tenaya Therapeutics (TNYA: $4.28) lifts 1.9%; +8c [1.9%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 14, 2024

Digital Resources/Online E-Resources

8
Weekly: Tenaya Therapeutics (TNYA: $4.20) tumbles 10% on weak volume; -48c [10.3%]
Material Type:
Newsletter Article
Add to My Research

Weekly: Tenaya Therapeutics (TNYA: $4.20) tumbles 10% on weak volume; -48c [10.3%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 13, 2024

Digital Resources/Online E-Resources

9
Tenaya Therapeutics (TNYA: $4.20) tumbles 6.2%; -28c [6.2%]
Material Type:
Newsletter Article
Add to My Research

Tenaya Therapeutics (TNYA: $4.20) tumbles 6.2%; -28c [6.2%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 11, 2024

Digital Resources/Online E-Resources

10
Tenaya Therapeutics (TNYA: $4.48) decreases; -3c [0.7%]
Material Type:
Newsletter Article
Add to My Research

Tenaya Therapeutics (TNYA: $4.48) decreases; -3c [0.7%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 10, 2024

Digital Resources/Online E-Resources

11
Tenaya Therapeutics (TNYA: $4.51) falls 2.2%; -10c [2.2%]
Material Type:
Newsletter Article
Add to My Research

Tenaya Therapeutics (TNYA: $4.51) falls 2.2%; -10c [2.2%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 9, 2024

Digital Resources/Online E-Resources

12
Tenaya Therapeutics (TNYA: $4.61) lifts 1.5%; +7c [1.5%]
Material Type:
Newsletter Article
Add to My Research

Tenaya Therapeutics (TNYA: $4.61) lifts 1.5%; +7c [1.5%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 8, 2024

Digital Resources/Online E-Resources

13
Tenaya Therapeutics (TNYA: $4.54) falls 3.0%; -14c [3.0%]
Material Type:
Newsletter Article
Add to My Research

Tenaya Therapeutics (TNYA: $4.54) falls 3.0%; -14c [3.0%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 7, 2024

Digital Resources/Online E-Resources

14
Tenaya Therapeutics (TNYA: $4.68) rises 1.3% on increasing volatility, hits 29-day high; +6c [1.3%]
Material Type:
Newsletter Article
Add to My Research

Tenaya Therapeutics (TNYA: $4.68) rises 1.3% on increasing volatility, hits 29-day high; +6c [1.3%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 4, 2024

Digital Resources/Online E-Resources

15
Weekly: Tenaya Therapeutics (TNYA: $4.68) jumps 9% - outperforming 95% of stocks; +37c [8.6%]
Material Type:
Newsletter Article
Add to My Research

Weekly: Tenaya Therapeutics (TNYA: $4.68) jumps 9% - outperforming 95% of stocks; +37c [8.6%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 6, 2024

Digital Resources/Online E-Resources

16
Health Care Roundup: Market Talk
Material Type:
Newspaper Article
Add to My Research

Health Care Roundup: Market Talk

The Wall Street journal. Eastern edition, 2024-05-14

Copyright 2024 Dow Jones & Company, Inc. All Rights Reserved. ;EISSN: 2574-9579

Digital Resources/Online E-Resources

Searching Remote Databases, Please Wait